<--- Back to Details
First PageDocument Content
Science / Research / Scientific method / Pharmaceutical industry / Drug safety / Institutional review board / Constitutional amendment / CHCA / Clinical trial / Clinical research / Design of experiments / Pharmacology
Date: 2014-07-30 03:58:53
Science
Research
Scientific method
Pharmaceutical industry
Drug safety
Institutional review board
Constitutional amendment
CHCA
Clinical trial
Clinical research
Design of experiments
Pharmacology

CALVARY HEALTH CARE ADELAIDE – HUMAN RESEARCH ETHICS COMMITTEE Document number: CHCA – HREC 1.3 Created on: November 23, 2011 Approved by: CHCA HREC Last review: August 2014 Page 1 of 2 Custodian: Nancy Olszewski Ne

Add to Reading List

Source URL: www.calvarynorthadelaide.org.au

Download Document from Source Website

File Size: 169,50 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document